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Long-Term Beta-Blocker Treatment Prevents Chronic Creatine Kinase 
and Lactate Dehydirogenase System Changes in Rat Hearts After 
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Ol&?etives. We tested tke hypothesis tbat long-term beta- 
blocker treatment with bisoprolol prevents creatioe kinase (CK) 
aad lactate dehydrognase system changes that occur after 
chronic myocardial infarction. 
l3ae&ad. The mechanism of the beneficiil e&t of beta- 
blocker therapy is still ~elear. 
M&ho&. Sii gmups of rats were studied. Sham operated 
(sham) and hearts with &ate@ i& =anterior dtxending cownary 
PrteIy (myocardial infarction) were ontreatwl, treated early (be- 
gbming 30 q dn after in&rction) or treated late (beginning 14 days 
after inhrction). After 8 weeks be& were isolated sod b&r 
perfused isovolmnetrIcally. With a left ventrieldar balloon, me. 
cbanical &n&ion was recorded st ali ~nhioistolic pressure of 
18 mm Hg. Biopsy samples of aoninhrcted left ventricular tissue 
were taken. Enzyme activities were rzasured spectrophtometri- 
eally; isoenzymes were sepamted by agar gel electropboresi$ and 
total creatine levels were measured with bigb performance liioid 
homatqrapby. 
lttwt&. Tbe decrease in left ventrhdar developed pressure in 
~trestedhcarts(lU)-c9vs104i:§mmHg[megn+SE],pc 
0.05, sham vs. q yocardiil infarction) after myocardial infarction 
In recent large clinical trials, mortality was reduced by heta- 
adrenergic blocking agents in patients with heart failure result- 
ing from dilated cardiomyopathy but not in patients with a 
history of myocardial infarction (1). In contrast, in patients 
treated for myocardial infarction with beta-blockers, benefit 
was related to cardiac dysfunction (2). This apparent paradox 
remains unresolved and underlines our lack of understanding 
of the mechanisms of beta-blocker therapy in patients with 
chronic heart failure. Lowering heart rate may be one major 
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was prevented by early treatment (118 -c 9 vs. 113 I 4 mm Hg). 
Late treatment failed to improve mecbanicat function. Beductioo 
of CK activity occunhg in untreated infarcted kearts (6.4 % 03 
vs. 5.1 2 03 IU/mg protein, p C 0.05, sham vs. myaxr4ial 
infarction) was prevented by early beta-blocker tberqy. Tbe 
increase in CK isoenzyme BB and MB levels, decrease io mito- 
cbomlrial CK isoenqme levels and increase in anaerobic lactate 
dekydqenase isoensyme leveh in unt~&&d infarcted bearts did 
oat occur during bisoprolol h&neztt. Tbe decrease in total 
creatine levels after myorardial infa& (74.2 2 4.9 vs. 54.9 f 
33 q mohg proteia, p < 0.05, sham v3. q yocardial infarctii) 
wns pmmted by bisoprolol treatment. Early treamt was more 
e&dive tban late tkerapy in preventing CK and lactate debydro- 
genase system ckanges. Ia addition, in sbam harts, a 40% 
increase of creathe levels above normal levels was detected. 
m. Bisoprohd prevented changes in CK and lactate 
dekydrogenase systems tbat occur after myomrdii infarction. 
Tbeseobse-rvatioasmayberelatedtotkebeneh&le6ectsof 
long-tern behblocker treatment in patiwts with cbrooic myo- 
cardii inbrction. 
(J Am cdl c.hiid 1996;27:487-93) 
beneficial effect (3-S); others may be a&rhythmic actions 
(6.7) or up-regulation of beta-receptor density (3.4). Various 
studies on patients with heart failure showed a hemodynamic 
benefit of chronic beta-blocker treatment (8). Beta-blockade m 
heart failure improved exercise capacity, left vzntricular ejec- 
tion fraction, stroke and cardiac index ant arteriovenous 
oxygen difference. Myocardial oxygen consumption was un- 
changed despite the increase in cardiac mechanical, work, 
implying that beta-blocker therapy was energetically favqrable 
for the heart. However, data are inconclusive, and studies have 
been hampered by inhomogeneity qf diseases underlying heart 
failure and variation of therapeutic regimens. 
The dilated heart faces chronically increased wall strts (9) 
and energy demand. In an animal model of chronic myocardial 
infarction. we have previously shown that energy reserve of 
residual intact myocardium is impaired with substantial reduc- 
tions of creatine phosphate, total creatine, total creatine kinase 
(CK) and mitochondrial CK isoenzyme (mito-CK) activity and 
a shift of lactate dehydrogenase isoenzymes towards anaerobic 
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metabolism (10). With the same infarcted rat heart model, the 
purpose of the present study was to test whether beta-blocker 
treatment with bisoprolol prevents CK and lactate dehydroge- 
nase system changes. In addition, we tested late treatment 
versus early treatment after myocardial infarction. 
Methrjds 
Animals aad experimental qyocardial infarction. Left an- 
terior descending coronary artery ligations were induced in 
12-week old male Wistar rate 1s previously described (11). A 
left thoracotomy was performed under ether anesthesia and 
positive pressure ventilation. The heart was rapidly exterior- 
ized by applying gentle pressure on both sides of the thorax. 
The left anterior descending coronary artery was ligated 
between the pulmonary artery outflow tract and the left 
atrium. After replacement of the heart into the thorax, the 
lungs were intlated by increasing positive end-expiratory pres- 
sure, and the wound was closed immediately. Sham operations 
were performe” A using an identical procedure, except hat the 
suture was passed under the coronary artery without ligation. 
For the first 24 h, the postoperative mortality rate of infarct 
gmup was 40% to 50%. The surviving rats were kept on 
standard rat chob, and water ad libitum. All procedures 
conformed to the guiding principles of the American Physio- 
logical Society. 
Study groups. Preliminary experiments were performed to 
find a k dynamically effective dose for beta-blocker t eat- 
ment: 6G +/kg body weight per day in drinking water de- 
creased ’ art rate in vivo from 402 t 24 beats/min (mean 2 
SE) in untreated rats (n = 5) to 321 t- 25 beatslmin in 
bisoprolol-treated rats (n = 5, p < 0.05). Smaller dosages did 
not reduce heart rate significantly. 
Six groups of rats were studied: untreated rats with sham 
operation (sham) or left anterior descending coronary artery 
ligation (myocardial infarction), sham or myocardial infarction 
rats treated with bisoprolol starting 30 min after infarction 
(sham B and myocardial infarction B) and sham and myocar- 
dial infarction rats in which bisoprolol treatment started 14 
days after infarction (sham 14 d B and myocardial infarction 14 
d B). During the following 8 weeks, one untreated rat, one rat 
from the early treatment group and three from the late 
treatment group died. Thus, 8 weeks postoperatively, we 
studied 11 untreated sham and 13 untreated myocardial infarc- 
tion rats, 12 late-treated sham and I3 late-treated myocardial, 
infarction rats and 9 early-treated sham and 14 early-treated 
myocardial infarction hearts, Bisoprolol treatment was stopped 
1 day before isolating the heart to exclude effects of acute 
beta-blockade on our measurements. Bisoprolol is known to 
have an elimination half-life of 9 to 12 h (12). 
1s@&d rat heart prepamtIon. Rats were anesthetized 8 
weeks after idadOn by injection of 20 mg pentobrbital 
sodium &aperitoneally. A transverse laparotomy and a left 
and a right antemlateral thoracotomy were performed. The 
heart w6s rapid@ excised and immersed in ice-cold bulfer. At a 
coilatant emperature of 37”C, retrograde perfusion of the 
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heart via the aorta was started in the LangendorE mode at a 
constant coronary perfusion pressure of 100 mm Hg. Krebs- 
Henseleit buffer of the following composition was used (in 
mmol/liter): sodium chloride 118.0, potassium dihydrogen 
phosphate 1.2,‘potassium chloride 4.7, magnesium sulfate 1.2, 
calcium chloride 1.75, disodium EDTA 0.5, glucose 11.0, 
sodium bicarbonate 25.0. Buffer was freshly made each day and 
was equilibrated with 95% oxygen + 5% carbon dioxide, 
yielding a pH of 7.4. The root of the pulmonary artery was cut 
open to allow for righ: ventricular outflow. The Row of the 
Thebesian veins was drained with a small polyethylene tubing 
pierced through the apex of the left ventricle. The heart was 
surrounded by its own pcrfusate in a water-jacketed reservoir. 
The perfusate level was kept constant immediately above the 
pulmonary outflow tract by continuous uction. 
Cardiac performance measurements. A water-filled latex 
balloon was inserted into the left ventricle through an incision 
in the left atrium and was secured by a ligature. The balloon 
was connected to a Statham P23Db pressure transducer 
(Gould Instruments) by a small-bore stainless-steel tube. By 
varying the filling volume of the balloon, an end-diastolic 
pressure of 10 mm Hg was set; left ventricular pressure and 
heart rate were continuously recorded on an eight-channel 
recorder (Polygraph, ZAK). 
Determination of infarct size. Because tissue was needed 
for biochemical measurements, the heart was separated into 
atria, right ventricle, left ventricular free wall, septum and scar 
after performance measurements. Each part was weighed. A 
sample of about 100 mg of intact left ventricular wall was taken 
for biochemical measurements. Infarcted hearts with a scar 
weight less than 200 mg were excluded. Each piece of scar was 
flattened between two glass plates. Photographs were taken 
with millimeter paper as background to determine scar area. 
Left ventricular volume was used to calculate left ventricular 
surface area. Infarct size was calculated as the percent of scar 
area in surface area. This method was previously shown to 
correlate closely with infarct size determined by standard 
morphologic techniques (13). 
High performance tiquid chrorsatagraphic measuremeats. 
Tissue was homogenized in 0.42 m3l/liter perchloric acid using 
the Potter S homogenizer (B. Brawn Melsungen AG), keeping 
the sample temperature at 4°C. After aliquots for protein 
measurements (14) were taken, 1 nol/liter potassium hydrox- 
ide was added to set a PH of about 5. The sample was 
centrifuged, fiitered and Injected into the high performance 
liquid chromatographic (XPLC) sptem for determination of 
total creatine. The HPLC system consisted of a pump (Waters 
Model 590, Millipore GmbH), an automatic injection system 
(Waters 712 WISP, Millipore GmbH). a spectrophotometer 
(Waters 486 Tunable Absorb:mce Detector, Millipore GmbH), 
a recorder (Waters 740 Data Module, MiNipore GmbH) and a 
reversed-phase column (Supelcosil LC-18.15.0 cm x 4.6 mm, 
S~pelco Deutschland GmbH). The 2cm guard column had the 
same stationary phase as the HPLC column: spherical 5-pm 
particles on a silica core with C-18 coating. The chromatogra- 
phy was run at room temperature and the wavelength of the 
JACC Vol. 21, No. 2 
Fehnm-y 1996~487-93 
T&e 1. Infarct Size, Left Ventricular Weight and Body Weight 
Untreated Laie Early 
Sham ” == 11 St = 12 tl=9 
MI n = 13 n- 13 ” = 14 
InfarcZ size (‘6) 
Sham - - - 
MI 3622 3.5 + 2 36:2 
Lvw k) 
Sham I.06 = 0.04 I).% 2 0.04 0.94 2 0.06 
MI 1.10 It 0.0.5 09x 2 0.03 0.92 2 If.04’ 
BW k) 
Sham 479525 46oz13 457 i 23 
MI SIX II4 462+17 44fJ z 14’ 
LWUBM (fWt9 
Sham 2.27 2 0.14 LOY 2 0.07 2.01 2 0.07 
MI 2.14 e 0.09 2.13 2 0.07 2.M 2 n.08 
*p < 0.05 treated versus untreated rats. Data presented are mean value 2 SE 
or number of rats. BW = bdy weight: LVW = left ventricular weight; MI = left 
anterior descending coronq artery-ligated hear&: Sham = shamoperated 
hearts. 
detector was set at 206 nm. The mobile phase consisted of 
potassium dihydrogen phosphate (215 mmohliter), tetrabmyiam- 
moniumhydrogen sulfate (2.3 mmol/liter) and acetonitriie (35%). 
A similar method was descrii by SeUevoid et at. (15). 
Enzyme measorements. Each sample (5 to 10 mg of tissue) 
was homogenized in 0.1 mot/liter phosphate buffer, pH 7.4, 
containing 1 mmoifliter EGTA and 1 mmohliter beta- 
mercaptoethanoi. Before 0.1% Triton X was added, aiiquots 
for measurement of protein were taken. Ail samples were kept 
on ice. The following enzyme activities were measured using an 
Uitraspec III spectrophotometer (Pharmacia Biosystems): CK 
(16) lactate dehydrogenase (17) and citrate synthase (18). The 
isoenzymes of lactate dehydrogenase were determined with the 
Titan Gel LD isoenzyme System (Helena Diagnostika GmbH) 
using agarose gel eiectrophoresis. To measure the CK isoen- 
zyme distribution, the Rapid Eiectrophoresis System (REP, 
Helena Diagnostika GmbH) was used as separation unit, and 
the REP CK &forms kit (Helena Diagnostika GmbH) for 
agarose gel and incubation solution were used. The agarose pi 
contams a Tris/barbitai buffer with sodium azide as preserva- 
tive. The Eiectrophoresis Data Center (EDC, Helena Diag- 
nostika GmbH) automatically quantified the separated isoen- 
zyme bands. 
Statistical analysis. All data are presented as mean value 
2 SE. For comparison of thz six groups (sham, myocardiai 
infarction, sham 14d B, myocardiai nfarction 14d B, sham B 
and myocardial infarction B), a one-factor analysis of variance 
(ANOVA) with the Games-Howell test was used as post hoc 
test. Statistical calculations were guided by the SuperANOVA 
statistics program (.bacus Concepts, inc.). 
Results 
Infarct size, body weight and vembrieolrv weight. Average 
infarct sizes (Table 1) were comparable for all treatment 
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Table 2. t.& Ventkhr Developed PresSwe and Heart Rate 
Sham 
MI 
LVDP (mm Hg) 
Sham 
Ml 
HR (beats min) 
Sham 
MI 
Cntrcated 
n- II 
n= 13 
12n-99 
Iv4 -5’ 
235 f 4 
xi 1 I I 
Biwprolol Tredtmcnt 
LSIV t;irfy 
” = I? !I=9 
n = 13 ” = 14 
IlVil 118r9 
105 f II,’ 113-4 
‘p c 0.05. left anterior descending coronaq artct+g&d heam (MI) 
versus ham-operated hearts ISham). Data presented arc mean value t SE or 
number of rats. HR = hean rale: LVDP = left ventricular doekwd prwre 
ai enddiartolk prewwi of 111 mm Hg. 
groups. Infarcted rats in the eariy-treated group showed re- 
duced body weights (518 + 14 vs. 446 L 14 g p < 0.05, 
myocardiai nfarction vs. myocardiai infarction B) and reduced 
left ventricular weights (1.10 -C 0.05 vs. 0.92 2 0.04 g. p < 0.05, 
myocardiai infarction vs. myocardiai infxction B). but no 
significant differences occurred in the ratio of left ventricular 
weight to body weight among groups. 
Pelfolmance of bEalted and astreated tntati hearts. 
Table 2 shows performance data from treated and untreated 
infarcted hearts under control conditions at an enddiastolic 
pressure of 10 m m  Hg. Left ventricular developed pressure was 
significantly redxxd in untreated hearts after myucardiat 
infarction (120 + 9 vs. 104 -C 5 m m  Hg p < 0.05, sham vs. 
myocardial imarction). This decrease of mechanical function 
was prevented by early (118 t 9 vs. 113 i 4 m m  Hg, sham vs. 
myocardiai infarction) but not by late bisoprolol therapy 
(119 2 7 vs. 105 2 6 m m  Hg, p < 0.05. sham vs. myocardiai 
infarction). Bisoproioi treatment was stopped 1 day befors 
isolating the heart to avoid acute effects of beta-blocker 
treatment, and heart rate did not differ among the various 
grow 
Creatine lriense system. Creatine kinase activity of intact 
left ventricuiar tissue was reduced after infarction (6.4 f 03 vs. 
5.1 t 0.2 IU/mg protein. p < 0.05, Fig. 1A). Bisoproloi 
treatment starting early preserved total CK activity at normal 
levels in infarcted !rearts. whereas late treatment failed to 
prevent the decrease in CKactivity. The relative dtstriiticm of 
the four CK isoenzymes BB, MB, M M  and mit~ochondriai CK 
(mito-CK) changed after myocardiai infarction (Fig. 1, B to E). 
The increase in the percentage of the BB isoenzyme ,$ter 
myocardiai infarction in untreated hearts (2.2 t 03% vs. 5.1 2 
0.4%, p < 0.05. sham vs. myecardiai in&tion) was reduced in 
the late treatment group to 3.3% and in the early treatment 
group of 2.4%. Similar changes were found for the MB 
&enzyme: Bisoproloi reduced the increase of the MB isoen- 
zyme completely (early treatment) or partially (late treat- 
ment). The M M  percentage did not change in ail groups.’ The 
sign&ant decrease of mit+CK after infarc=ion (34.8 Y! 0.8% 
vs. 265 Ic 1.24, p < 0.05) was prevented by both late (33.0 2 
8 
h 6 
i: 
0 
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Figure 1. A to F, Effects of late and early 
bisoprolol (Biso) treatment on creatine kinasc 
(CK) activity, CK-isoenzyme distribution and 
and total CK after myocardial infarction. *p < 
0.05, myocardial infarction (soiii bars) versus 
sham (gray bars); +p < 0.05, treated versus 
untreated rats for n = 11 (sham untreated), 13 
(myocardidl infxction untreated), 12 (sham 
with late bimprolol treatment). 13 (myocardial 
infarction with late bisoprolol treatment), Y 
(sham with early bisoprolol treatment), 14 
(myocardial infarction with early bisoprolol 
treatment). Cr = seatine: Pr = protein 
1.2% vs. 30.3 + 0.8%) and early treatment (32.5 I! 1.3% vs. (LDH4. 13.7 2 1.1 vs. 13.7 + 0.7; LDHS, 4.0 t 0.3 vs. 5.2 + 
32.8 + 1.9%). Thus, delayed bisoprolol therapy showed direc- 0.6); late treatment prevented the increase in part (LDH4, 
tionally similar but quantitatively smaller effects than early 12.7 I! 0.9 vs. 15.1 -t 0.8; LDHS, 4.8 rf: 0.5 vs. 6.7 ? 0.6) (Fig. 
therapy on the CK system. 2A-E). The activity of citrate synthase (IU/mg protein), a 
After myocardial infarction, t&al ereatine content (Fig. 1F) marker enzyme for mitochondriai mass, was comparable for all 
decreased (74.2 5 4.9 vs. 54.9 2 3.3 nmol creatine/mg protein, groups: 0.64 + 0.04 versus 0.62 2 0.03 (sham vs. myocardial 
p < 0.05, sham vs. myocardial infarction) in residual intact left infarction) in untreated groups, 0.71 2 0.05 versus 0.73 + 0.04 
ventricular myocardium. Early and late bisoprolol treatment in late-treated groups and 0.80 -? 0.06 versus 0.74 2 0.04 in 
completely prevented the reduction of creati,?e. Again, treat- early-treated groups (all p = NS, sham vs. myocardial infarc- 
ment starting immediately after infarction showed more sub- tion). Thus, mitochondrial mass estimated ds citrate synthase 
stantial effects than late treatment. However, surprisingly, in activity did not change after myocardlal : lfarction or by 
bisoprolol-treated sham hearts, creatine content increased sig- bisoprolol treatment. 
nificantly above control levels of untreated sham hearts 
(74.2 2 4.9) after early (107.7 t 5.7 nmol creatine/mg protein, 
p < 0.05) and late treatment (101.1 ? 6.2 nmol creatine/mg Discussion 
protein, p < 0.05). Hypertrophy. Quantitative histologic studies have shown 
Lactate dehydmgenase and citrate synthase. Lactate dehy- that surviving myocytes after myocardial infarction increase in 
drogen.tse (LDH) activity was unaffected by myocardial infarc- length and diameter (19). This is the morphotogic substrate of 
tion and biiprolol therapy in untreated groups (0.94 t 0.07 the present biochemical studies. The fact that in our study left 
vs. 0.98 t- 0.0s; sham vs. myocardial infarction), in late-treated ventricular weight remained unchanged despite loss of myo- 
groups (0.84 + 0.04 vs. 0.75 t 0.05) and early-treated groups cardium from infarction and development of a thin scar 
(1.03 2 0.07 vs. 0.97 + 0.06). The anaerobic isoenzymes LDH4 suggests hypertrophy. Iiowever, left ventricular weight or the 
(13.8 2 0.9 vs. 20.0 i: 1.3, p < 0.05) and LDHS (4.5 ? 0.3 vs. ratio of left ventricular weight to body weight is only a crude 
78 t 0.7, p < 0.05) increased signilicantly after myocardial measure for hypertrophy and does not necessarily reflect the 
infarction. This was completely prevented by early treatment inhomogeneous changes at the cellular level. Previous studies 
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Fii 2. A to P Effects of late and earlv 
b&prolol (Biro) ‘treatment on the distribi- 
tion of the tive lactate dehydrogenase (LDH) 
isoenzymn after myocardial infarction. *p < 
0.05, myocardial infarction (solid bars) versus 
sham (gray bars); Sp < 0.05 treated versus 7.7 20 
untreated rats for n = 11 (sham untreated). I IT 3 
’ 
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(myocardial infarction with late bisoprotol 
13 (myoeardial infarction untreated), t2 
(sham with late hiiprolol treatment), 13 
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5 
9 1 
treatment). 9 (sham v.ith earty bisoproto) 
treatment), 14 (myocardial infarction with mtrwted late&so edyaK 
early bisoprolol treatment). 
E 
35 
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& 2o 
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0 
using the same rat infarct model have suggested that beta- after long-term Lk%Alockade (71). In tbil latter t,udv ha- 
blocker treatment blunts hypertrophy but promotes left ven- blocker treatment was started 3 weeks after coronary l.:.&on. 
tricular dilation at the same time (20,21), with a net result of similar to the late-treatment protocol in the presen study. 
unchanged left ventricular weight after beta-blockade in in- which did not prevent deterioration of left ventricular perfor- 
farcted hearts. Thus, bisoprobl may have bad effects on mance. Thus. the conflicting results may in part be explained 
morphology not reflected in the present study. by the digerent treatment regimens (early vs. late). 
Mecbaoieal Bmctinn. Only limited data have been pre- CreathK kinase aad laetnte dehy&ugen~ systems. The 
sented on functional effects of beta-blockade on surviving major result of the present study was that bboprolol treatment 
myocardium after myocardial infarction. Our data support the prevented an increase in the anaerobii lactate dehydrogenase 
hypothesis that long-term beta-blocker treatment started early &forms, the shift toward the fetal CR isoenzymes BB and MB 
after myocardial infarction may in part prevent deterioration and the depletion of creatine, which we previously dexribed 
of mechanical function. Clearly, using developed pressure in a atier myocardial infarction (IO). During development from 
Langendorif preparation to measure left ventricular function fetal to adult myocardium. total CK actMy and mito-CK 
has limitations. Loading conditions in vivo may be quite increase. whereas the fetal isoenzymes BB amt MB decrease 
different, and geometric changes of the heart will greatfy (22). The increase in fetal isoenzymes BB and MB is a uniform 
influence left ventricular function (13). Long-term beta- stress ttqcme observed after chronic coronary artery occh~- 
adrenergic blockade improved basal isometric contraction in sion in the dog (23). in rat and dog facing pressure or volume 
noninfarcted isolated papillary muscle in rats after myocardial overload or hypertension (24-26) and in myocardium of 
infarction. a model that eliminates the influence of geometric patients with vafvular aortic stenosis or coronary tirtery disease 
chenges of left ventricle (3). Although these investigators (27). This isoenzyrue shift was interpreted as an adaptive 
founds an up-regulation of beta-adrenoreceptor density after mechanism, because the adinity of the fetal B-tlrpe hoenzymes 
propranolol treatment, it is unlikely to be the reason for for creatine phosphate is higher than the afftnity of the M M  
improved mechanical performar~~ because adenyfate cydase iswnzyme, making the phosphoryf tramkr hrn creatine 
activity was still impaired (3). Med&cal function measured phosphate to &xtosine triphosphate (ATP) more efhcient. In 
in vivo in rats post-myocatdhd infarction was not improved the failing myocardium of I8-month old spontaneously hyper- 
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tensive rat, reductions of total CK activity, mito-CK and total 
creatine occur in addition (24). Increases of anaerobic lactate 
dehydrogenase were also described in biopsy samples of pa- 
tients with severe chronic heart failure (28). 
rate. Either one would be important, however, and the data 
suggest so far unknown effects on beta-blockade in chronic 
cardiac dysfunction. 
Effects of beta-blockade on hypertrophy and on the adren- 
ergic sysiem might prevent these CK and lactate dehydroge- 
nase changes. Chronic tissue hypoxia may be a possible trigger 
mechanism (27) or high serum catecholamine levels (29). In 
addition, beta-blocker treatment might have an energetically 
favorable effect by chronically reducing heart rate, rendering 
the adaptive increase of CK and lactate dehydrogenase iso- 
forms unnecessary. Clearly, further studies are required to 
address the mechanism and the importance for myocardial 
function of this beta-blocker effect. The lactate dehydrogenase 
system changes are unlikely to be of significance for myocardial 
function, because lactate dehydrogenase is not a rate-limiting 
enzyme in the glycolytic pathway. This may, however. indicate 
prevention of a shift tc chronic anaerobic metabolism. 
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